CSU Havemeyer Symposium on Orthobiologics

By /

I’m at the CSU Havemeyer Symposium on orthobiologics this morning. This marks the opening of the C. Wayne McIlwraith Translational Medicine Institute (TMI). How does all of this intersect with what I do?

Our Work with CSU

Way back when in 2004, I wanted to begin using mesenchymal stem cells to treat our patients with spine pain, I sat down at a computer to search to find someone in our local area who knew what to do with this stuff. I soon found John Kisiday, a new professor at CSU. After meeting with John, it became clear that CSU had just begun using MSCs to treat athletic horses and the rest was history. We began translating that technology, with changes, to humans. That was way back in 2005.

Join us for a free Regenexx webinar.

John Malone and Orthobiologics

I first met with John Malone a bit less than a decade ago and learned of his interest in medicine. John is a billionaire philanthropist who had already donated chairs and buildings in bioengineering and personalized medicine to Yale and Johns Hopkins. I worked with John on helping Regenexx get its start and on funding the Interventional Orthopedics Foundation (IOF). Eventually, John decided to donate the key funding for the TMI at CSU.

Wayne McIlwriath and Stem Cells

Wayne is a veterinarian orthopedic surgeon at CSU and one of the fathers of orthopedic stem cell therapy. He is also the father of arthroscopic surgery and has published extensively in both areas. Wayne has been a mentor of mine for years and is now on the board of IOF.

Join us for a free Regenexx webinar.

Havemeyer Symposium

This is a closed meeting of many orthobiologic leaders such as Wayne, Jason Dragoo from Stanford, Ashlee Watts from Texas A&M, Brian Cole from Rush, Christian Latterman from Harvard, Ted Schlegel from CU, Brain Johnstone form OHSU, Frank Barry from NUI Galway, Johnny Huard from University of Texas, Thomas Koch University of Guelph, and Chris Little of the University of Sydney. The goal is to present our research to each other.

The upshot? This should be a great next few days to better understand how to work with other physician and university scientists on how best to improve orthobiologics. Onward and upward!

Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

Get Blog Updates by Email

By submitting the form, you are agreeing that you read and consent to our Privacy Policy. We may also contact you via email, phone, and other electronic means to communicate information about our products and services. We do not sell, or share your information to third party vendors.

Category: Uncategorized
Copyright © Regenexx 2021. All rights reserved.



9035 Wadsworth Pkwy #1000
Westminster, CO 80021


*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.